Dr. Lanfranchi: The Perilous Pill

Judie Brown
By Rita Diller
June 7, 2012
Reproduced with Permission

Dr. Lanfranchi: The perilous pill Dr. Angela Lanfranchi is an expert on the perils of the pill. Her first patient was a young woman who had a stroke because of pill usage and as a result was hemiplegic (paralyzed on one side of her body). Now a breast surgeon, Dr. Lanfranchi spends her days operating on cancerous breasts. Many of her patients have been duped by Planned Parenthood and its cohorts into believing that the birth control pill is the ultimate good, and that any risks that accompany it are so small as to be inconsequential.

In her June 2 presentation at ALL's national symposium on the pill, she outlined the four major mechanisms by which the pill kills women, showing them to be anything but inconsequential: (1) The pill causes blood clots which can result in heart attack, stroke, or fatal pulmonary embolism; (2) the pill causes cancer; (3) the pill makes it easier to get potentially lethal infections; and (4) the pill makes it more likely users will die violent death.

Blood clots: Dr. Lanfranchi presented studies that show that women who use the pill have twice the risk of myocardial infarction (heart attack), twice the risk of stroke, and two to three times the risk of pulmonary embolism, because of increased blood clotting. Women on pills like Yaz and Yasmin that contain androgenic progestins have an additional 60-80 percent risk of venous thromboembolism (VTE). That explains why the manufacturer of these drugs will reportedly pay at least $100 million to settle some 500 lawsuits filed by women who have been victims of the drugs.

Women with hereditary conditions that cause clotting have even higher rates of VTE, yet women are very seldom screened for these conditions and are rarely warned of the extremely high danger they are incurring by taking the pill.

Cancer: In 2000, the National Toxicology Advisory Panel put estrogen on its list of carcinogens. There are metabolites of estrogen which directly damage DNA causing mutations and cancer.

But what about the claim that the pill prevents some cancers, while increasing the risk of others, making it a "wash"? In 2005, the UN's International Agency on Research of Cancer (IARC) reported in its Monograph 91 that estrogen-progestin combination drugs (the pill) were a Group 1 carcinogen for breast, cervical, and liver cancer. Although the risk of uterine and ovarian cancers was lower on the pill, there is six times more breast cancer in women than uterine and ovarian cancers combined. Any cancer-preventing benefits are greatly outweighed by the breast cancer risk posed.

Long-term pill use increases the risk of cervical cancer. Women who use the pill for five to nine years have twice the risk of cervical cancer. Those who use it for 10 years or more have more than three times the risk of cervical cancer.

In fact, since 1975, the risk of in-situ (early stage) breast cancer has increased 400 percent in premenopausal women.

Primary liver cancer, rare in developed countries, is increased 50 to 70 percent in women who use the pill.

Lethal infections: Women on the pill increase their risk of getting HIV 60 percent when compared to women not taking the pill. Women on the pill were twice as likely to transmit HIV to their partners. And women on the pill are twice as likely to get infected with HPV (human papillomavirus).

Violent death: Two 2010 studies reported a higher rate of violent death among those who had used contraception at some point in their lifetime compared to those who had not, with one study showing that the rate of violent death increases with longer duration of oral contraceptive use.

The Pill Kills Babies: Dr. Lanfranchi explained that the pill is an abortifacient. Women on the pill have light menstrual periods because the pill reduces the thickness of the endometrial lining, resulting in difficulty of implantation of the embryo after conception has occurred, which can result in an early abortion.

The pill also results in biochemical changes such as in the levels of interleukins, which are molecules necessary for implantation.